Alzheimer's disease.

TitleAlzheimer's disease.
Publication TypeJournal Article
Year of Publication2006
AuthorsBlennow K, de Leon MJ, Zetterberg H
JournalLancet
Volume368
Issue9533
Pagination387-403
Date Published2006 Jul 29
ISSN1474-547X
KeywordsAged, Alzheimer Disease, Animals, Cholinesterase Inhibitors, Donepezil, Galantamine, Humans, Indans, Male, Molecular Biology, Phenylcarbamates, Piperidines, Plaque, Amyloid, Positron-Emission Tomography, Randomized Controlled Trials as Topic, Rivastigmine, tau Proteins
Abstract

Alzheimer's disease is the most common cause of dementia. Research advances have enabled detailed understanding of the molecular pathogenesis of the hallmarks of the disease--ie, plaques, composed of amyloid beta (Abeta), and tangles, composed of hyperphosphorylated tau. However, as our knowledge increases so does our appreciation for the pathogenic complexity of the disorder. Familial Alzheimer's disease is a very rare autosomal dominant disease with early onset, caused by mutations in the amyloid precursor protein and presenilin genes, both linked to Abeta metabolism. By contrast with familial disease, sporadic Alzheimer's disease is very common with more than 15 million people affected worldwide. The cause of the sporadic form of the disease is unknown, probably because the disease is heterogeneous, caused by ageing in concert with a complex interaction of both genetic and environmental risk factors. This seminar reviews the key aspects of the disease, including epidemiology, genetics, pathogenesis, diagnosis, and treatment, as well as recent developments and controversies.

DOI10.1016/S0140-6736(06)69113-7
Alternate JournalLancet
PubMed ID16876668
Grant ListR01 AG022374 / AG / NIA NIH HHS / United States
Related Institute: 
Brain Health Imaging Institute (BHII)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065